Get started
Author

Kim Wedervang

Observed names: K Wedervang, K. Wedervang, Wedervang, Kim
ORCID: 0009-0004-4789-3536
Observed ORCIDs: 0009-0004-4789-3536, 0000-0001-9708-5642
OpenAlex ID: A5001642107
Phase III randomized clinical trial comparing the efficacy of neoadjuvant chemotherapy and standard treatment in patients with locally advanced colon cancer: The NeoCol trial.
2023 · Lars Henrik Jensen, Monica Linda Kjaer, et al. · Journal of Clinical Oncology · 52
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC—Real World Efficacy
2021 · Mette T. Mouritzen, Andreas Carus, et al. · Cancers · 44
PDF
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)
2024 · Nicholas Turner, Cristina Saura, et al. · Journal of Clinical Oncology · 42
PDF
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study
2022 · Mette T. Mouritzen, Karen F. Junker, et al. · Acta Oncologica · 19
PDF
Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy
2022 · Birgitte Bjørnhart, Charlotte Kristiansen, et al. · Thrombosis Research · 17
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy
2023 · Birgitte Bjørnhart, Mette Thune Mouritzen, et al. · Acta Oncologica · 16
PDF
Preliminary results of a phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
1997 · J B Sørensen, K Wedervang, et al. · PubMed · 10
The NAME Trial: A Direct Comparison of Classical Oral Navelbine Versus Metronomic Navelbine in Metastatic Breast Cancer
2019 · Sven Tyge Langkjer, Julia Kenholm, et al. · Future Oncology · 9
PDF
Severity and 1-month outcome of SARS-CoV-2 infection in patients with solid cancers: a Danish nationwide cohort study
2021 · S. Ehmsen, L. H. Jakobsen, et al. · Acta Oncologica · 8
PDF
Remote Symptom Monitoring of Patients With Advanced Lung Cancer (The ProWide Study): A Randomized Controlled Trial
2024 · Rasmus Blechingberg Friis, Helle Pappot, et al. · JCO Oncology Practice · 7
Mini Oral Sessions
2015 · Sloth Møller, Ditte, Andersen, Jon L, et al. · Journal of Thoracic Oncology · 7
PDF
Randomized phase III trial in extensive-disease small cell lung cancer comparing first-line etoposide to topotecan in combination with platinum.
2014 · Morten Mau-Soerensen, Olfred Hansen, et al. · Journal of Clinical Oncology · 4
Remote symptom-monitoring of patients with advanced lung cancer: A Danish national randomized controlled trial—The ProWide study.
2023 · Rasmus Blechingberg Friis, Helle Pappot, et al. · Journal of Clinical Oncology · 3
Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan
2023 · Morten Mau-Sørensen, Jonas Gerner-Rasmussen, et al. · Acta Oncologica · 1
PDF
1334P Real word experience with first-line immunotherapy in advanced non-small cell lung cancer patients in a Danish nationwide cohort
2020 · M. Mouritzen, B. Bjoernhart, et al. · Annals of Oncology · 1
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy
2023 · Bjørnhart, Birgitte, Mouritzen, Mette Thune, et al. · Figshare
1114P Long-term outcome in Danish real-life patients with advanced non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitors
2022 · B. Bjornhart, M. Mouritzen, et al. · Annals of Oncology
54P Impact of comorbidity and venous thromboembolism on outcome in real-life non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibition (ICI)
2020 · B. Bjoernhart, C. Kristiansen, et al. · Annals of Oncology
The NAME trial: A direct comparison of oral navelbine given either classic or metronomic in metastatic HER2 neg breast cancer
2018 · S.T. Langkjer, J. Kenholm, et al. · Annals of Oncology
218 Phase II study of bi-weekly paclitaxel (P) and cisplatin (C) for non-resectable non small-cell lung cancer (NSCLC)
1997 · J.B. Sørensen, K. Wedervang, et al. · Lung Cancer
Works count: 21
Citation count: 240
H-index: 8
I10-index: 7
Year
Topic
Type